PRLR-specific antibody and uses thereof
US7867493B2 · kind B2 · utility
31Cited by
0References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 17, 2007 |
| Grant date | Jan 11, 2011 |
| Priority date | — |
| Expiry date | Oct 5, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/72
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
PRLR-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.